مقاومة المضادات الحيوية في عزلات بكتيرية من عينات المياه العذبة ومياه البحر في مدينة زليتن - ليبيا

Vilca, F. Z., & Angeles, W. G. (2018). Occurrence of Antibiotics Residues in the Marine Environment. Examines Mar. Biol. Ocean, 2, 12-14.‏

Irfan, S., & Alatawi, A. M. M. (2019). Aquatic ecosystem and biodiversity: a review. Open Journal of Ecology, 9(1), 1-13.‏

Hassan, B., Qadri, H., Ali, M. N., Khan, N. A., & Yatoo, A. M. (2020). Impact of climate change on freshwater ecosystem and its sustainable management. Fresh Water Pollution Dynamics and Remediation, 105-121.‏

World Health Organization (2017). WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed. World Health Organization [Internet]Available: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (Accessed November 15, 2021).

World Health Organization (2021). Antimicrobial Resistance. World Health Organization [Internet]. 2021.

[Internet]Available: https://www.who.int/news-room/fact sheets/detail/antimicrobial-resistance (Accessed November 15, 2021).

Poretsky, R., Rodriguez-R, L. M., Luo, C., Tsementzi, D., & Konstantinidis, K. T. (2014). Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal microbial community dynamics. PloS one, 9(4), e93827.‏

Moyane, J. N., Jideani, A. I. O., & Aiyegoro, O. A. (2013). Antibiotics usage in food-producing animals in South Africa and impact on human: Antibiotic resistance. Afr. J. Microbiol. Res, 7(24), 2990-2997.‏

Batt, A. L., Kim, S., & Aga, D. S. (2007). Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations. Chemosphere, 68(3), 428-435.‏

Schwartz, T., Kohnen, W., Jansen, B., & Obst, U. (2003). Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms. FEMS microbiology ecology, 43(3), 325-335.‏

AbdelRahim, K. A. A., Hassanein, A. M., & Abd El, H. A. E. H. (2015). Prevalence, plasmids and antibiotic resistance correlation of enteric bacteria in different drinking water resources in sohag, egypt. Jundishapur journal of microbiology, 8(1).‏

Guzman-Otazo, J., Gonzales-Siles, L., Poma, V., Bengtsson-Palme, J., Thorell, K., Flach, C. F., ... & Sjöling, Å. (2019). Diarrheal bacterial pathogens and multi-resistant enterobacteria in the Choqueyapu River in La Paz, Bolivia. PLoS One, 14(1), e0210735.‏

Singh, A. K., Das, S., Kumar, S., Gajamer, V. R., Najar, I. N., Lepcha, Y. D., ... & Singh, S. (2020). Distribution of antibiotic-resistant Enterobacteriaceae pathogens in potable spring water of eastern Indian Himalayas: emphasis on virulence gene and antibiotic resistance genes in Escherichia coli. Frontiers in Microbiology, 11, 581072.‏

Guardabassi, L., Petersen, A., Olsen, J. E., & Dalsgaard, A. (1998). Antibiotic resistance in Acinetobacter spp. isolated from sewers receiving waste effluent from a hospital and a pharmaceutical plant. Applied and Environmental Microbiology, 64(9), 3499-3502.‏

Chagas, T. P. G., Seki, L. M., Cury, J. C., Oliveira, J. A. L., Dávila, A. M. R., Silva, D. M., & Asensi, M. D. (2011). Multiresistance, beta‐lactamase‐encoding genes and bacterial diversity in hospital wastewater in Rio de Janeiro, Brazil. Journal of applied microbiology, 111(3), 572-581.‏

Marathe, N. P., Shetty, S. A., Shouche, Y. S., & Larsson, D. J. (2016). Limited bacterial diversity within a treatment plant receiving antibiotic-containing waste from bulk drug production. PLoS One, 11(11), e0165914.‏

Turolla, A., Cattaneo, M., Marazzi, F., Mezzanotte, V., & Antonelli, M. (2018). Antibiotic resistant bacteria in urban sewage: Role of full-scale wastewater treatment plants on environmental spreading. Chemosphere, 191, 761-769.‏

Adbarzi, S. S. M., Tripathi, P., Choudhary, K. K., Kant, R., & Tripathi, V. (2020). Assessment of physico-chemical properties of pre and post-treated wastewater of Prayagraj region and its effect on nearby Ganges river. Vegetos, 33(2), 258-264.‏

Alexander, J., Hembach, N., & Schwartz, T. (2020). Evaluation of antibiotic resistance dissemination by wastewater treatment plant effluents with different catchment areas in Germany. Scientific Reports, 10(1), 8952.‏

Amarasiri, M., Sano, D., & Suzuki, S. (2020). Understanding human health risks caused by antibiotic resistant bacteria (ARB) and antibiotic resistance genes (ARG) in water environments: Current knowledge and questions to be answered. Critical Reviews in Environmental Science and Technology, 50(19), 2016-2059.‏

Chauhan, N. S., & Punia, A. (2023). Antibiotic pollution and antibiotic-resistant bacteria in water bodies. In Degradation of Antibiotics and Antibiotic-Resistant Bacteria from Various Sources (pp. 179-201). Academic Press.‏

Henriques, I. S., Fonseca, F., Alves, A., Saavedra, M. J., & Correia, A. (2006). Occurrence and diversity of integrons and β-lactamase genes among ampicillin-resistant isolates from estuarine waters. Research in microbiology, 157(10), 938-947.‏

Zhang, X. X., Zhang, T., & Fang, H. H. (2009). Antibiotic resistance genes in water environment. Applied microbiology and biotechnology, 82, 397-414.‏

Guo, X., Tang, N., Lei, H., Fang, Q., Liu, L., Zhou, Q., & Song, C. (2021). Metagenomic analysis of antibiotic resistance genes in untreated wastewater from three different hospitals. Frontiers in Microbiology, 12, 709051.‏

Berger-Bächi, B. (2002). Resistance mechanisms of gram-positive bacteria. International Journal of Medical Microbiology, 292(1), 27-35.‏

CytoGene Research & Development Laboratory : K-51, Agro Park, UPSIDC Industrial Area, Kursi Road (Lucknow) Dist-Barabanki – 2250.

Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C. & Yolken, R.H.. (1995). Manual of Clinical Microbiology, 6th edition. American Society of Microbiology Press, Washington DC. 1482 p.

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty Sixth Informational Supplement. CLSI Document M100-S26”. Wayne, PA: Clinical and Laboratory Standards Institute (2016).

World Health Organization (2014). Antimicrobial Resistance Global Report on Surveillance. Geneva: World Health Organization. Available at: https://apps.who.int/iris/handle/10665/112642 (Accessed November 12, 2021).

World Health Organization (2015). Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization. Available at: https://www.who.int/publications/i/item/9789241509763. (Accessed November 15, 2021).

Adler, A., Katz, D. E., & Marchaim, D. (2016). The continuing plague of extended-spectrum β-lactamase–producing Enterobacteriaceae infections. Infectious Disease Clinics, 30(2), 347-375.‏

Bush, K. (2018). Past and present perspectives on β-lactamases. Antimicrobial agents and chemotherapy, 62(10), 10-1128.‏

Bush, K., & Bradford, P. A. (2020). Epidemiology of β-lactamase-producing pathogens. Clinical microbiology reviews, 33(2), 10-1128.‏

Tacão, M., Laço, J., Teixeira, P., & Henriques, I. (2022). CTX-M-producing bacteria isolated from a highly polluted river system in Portugal. International Journal of Environmental Research and Public Health, 19(19), 11858.‏

Yamaguchi, A. (1997). Bacterial resistance mechanisms for tetracyclines. Nihon rinsho. Japanese Journal of Clinical Medicine, 55(5), 1245-1251.‏

Nawaz, M., Khan, A. A., Khan, S., Sung, K., & Steele, R. (2008). Isolation and characterization of tetracycline-resistant Citrobacter spp. from catfish. Food microbiology, 25(1), 85-91.‏

Poirel, L., Ros, A., Carricajo, A., Berthelot, P., Pozzetto, B., Bernabeu, S., & Nordmann, P. (2011). Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrobial agents and chemotherapy, 55(1), 447-448.‏

Raman, G., Avendano, E. E., Chan, J., Merchant, S., & Puzniak, L. (2018). Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrobial Resistance & Infection Control, 7, 1-14.‏

Tabak, Y. P., Merchant, S., Ye, G., Vankeepuram, L., Gupta, V., Kurtz, S. G., & Puzniak, L. A. (2019). Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the United States. Journal of Hospital Infection, 103(2), 134-141.‏

Kunz Coyne, A. J., El Ghali, A., Holger, D., Rebold, N., & Rybak, M. J. (2022). Therapeutic strategies for emerging multidrug-resistant Pseudomonas aeruginosa. Infectious diseases and therapy, 11(2), 661-682.‏

Livermore, D. M., Williams, J. D., & Davy, K. W. (1985). Cephalosporin resistance in Pseudomonas aeruginosa, with special reference to the proposed trapping of antibiotics by beta-lactamase. Chemioterapia: International Journal of the Mediterranean Society of Chemotherapy, 4(1), 28-35.‏

Kim, E. S., & Hooper, D. C. (2014). Clinical importance and epidemiology of quinolone resistance. Infection & chemotherapy, 46(4), 226-238.‏

Hooper, D. C., & Jacoby, G. A. (2015). Mechanisms of drug resistance: quinolone resistance. Annals of the New York academy of sciences, 1354(1), 12-31.‏

Adbarzi, S. S. M., Tripathi, P., Kant, R., & Tripathi, V. (2020). Assessment of bacterial diversity and their antibiotic resistance profiles in wastewater treatment plants and their receiving Ganges River in Prayagraj (Allahabad), India. Vegetos, 33(4), 744-749.‏

Berger-Bächi, B. (2002). Resistance mechanisms of gram-positive bacteria. International Journal of Medical Microbiology, 292(1), 27-35.‏

Munita, J. M., Bayer, A. S., & Arias, C. A. (2015). Evolving resistance among Gram-positive pathogens. Clinical Infectious Diseases, 61(suppl_2), S48-S57.‏

Duc, L. H., Hong, H. A., Barbosa, T. M., Henriques, A. O., & Cutting, S. M. (2004). Characterization of Bacillus probiotics available for human use. Applied and environmental microbiology, 70(4), 2161-2171.‏

Adamski, P., Byczkowska-Rostkowska, Z., Gajewska, J., Zakrzewski, A. J., & Kłębukowska, L. (2023). Prevalence and antibiotic resistance of Bacillus sp. isolated from raw milk. Microorganisms, 11(4), 1065.‏

O'Hara, C. M., Brenner, F. W., & Miller, J. M. (2000). Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clinical microbiology reviews, 13(4), 534-546.‏

Stock, I. (2003). Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains. Journal of chemotherapy, 15(1), 12-26.‏

Kim, B. N., Kim, N. J., Kim, M. N., Kim, Y. S., Woo, J. H., & Ryu, J. (2003). Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991–2000). Scandinavian journal of infectious diseases, 35(2), 98-103.‏

Owoseni, M. C., Oyigye, O., Sani, B., Lamin, J., & Chere, A. (2021). Antimicrobial resistance and Virulence genes profiling of proteus species from poultry farms in Lafia, Nigeria. BioRxiv, 2021-01.‏

Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995). A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrobial agents and chemotherapy, 39(6), 1211-1233.‏

Perilli, M., Segatore, B., Rosaria De Massis, M., Riccio, M. L., Bianchi, C., Zollo, A., ... & Amicosante, G. (2000). TEM-72, a new extended-spectrum β-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. Antimicrobial agents and chemotherapy, 44(9), 2537-2539.‏

Pagani, L., Migliavacca, R., Pallecchi, L., Matti, C., Giacobone, E., Amicosante, G., ... & Rossolini, G. M. (2002). Emerging extended-spectrum β-lactamases in Proteus mirabilis. Journal of clinical microbiology, 40(4), 1549-1552.‏

Song, W., Kim, J., Bae, I. K., Jeong, S. H., Seo, Y. H., Shin, J. H., ... & Lee, K. (2011). Chromosome-encoded AmpC and CTX-M extended-spectrum β-lactamases in clinical isolates of Proteus mirabilis from Korea. Antimicrobial agents and chemotherapy, 55(4), 1414-1419.‏

Philippon, A., Labia, R., & Jacoby, G. (1989). Extended-spectrum beta-lactamases. Antimicrobial agents and chemotherapy, 33(8), 1131-1136.‏

Stock, I. (2003). Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains. Journal of chemotherapy, 15(1), 12-26.‏

Gales, A. C., & Jones, R. N. (2000). Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates. Diagnostic microbiology and infectious disease, 36(1), 19-36.‏

Mokracka, J., Gruszczyńska, B., & Kaznowski, A. (2012). Integrons, β-lactamase andqnrgenes in multidrug resistant clinical isolates ofProteus mirabilisandP. vulgaris. APMIS, 120(12), 950-958.‏

Guillard, T., Grillon, A., de Champs, C., Cartier, C., Madoux, J., Berçot, B., ... & Cambau, E. (2014). Mobile insertion cassette elements found in small non-transmissible plasmids in Proteeae may explain qnrD mobilization. PLoS One, 9(2), e87801.‏